Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brief report: Artificial intelligence meets small cell lung cancer-integrating clinicopathological and wholeslide image data for prognostic prediction in SCLC.

Frontiers in artificial intelligence·2026
Same author

Computational Identification of Potential Novel Allosteric IHF Inhibitors Using QSAR Modeling to Inhibit Plasmid-Mediated Antibiotic Resistance.

International journal of molecular sciences·2026
Same author

Accelerating real-world prediction and research in Alzheimer's: The M3AD study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Dual Subsartorial Block: An Analgesic Technique Targeting the Popliteal Plexus of the Knee in Anterior Cruciate Ligament Reconstruction-A Case Series.

A&A practice·2026
Same author

Efficacy of a Standardized Low-Dose Insulin Infusion Protocol in the Emergency Stabilization of Diabetic Dogs.

Veterinary sciences·2025
Same author

Testing an augmented reality-based learning sequence for renal physiology with biomedical students.

Advances in physiology education·2025

Related Experiment Video

Updated: May 30, 2025

Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors
09:11

Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors

Published on: November 23, 2019

6.6K

A Simple Machine Learning-Based Quantitative Structure-Activity Relationship Model for Predicting pIC50 Inhibition

Jackson J Alcázar1, Ignacio Sánchez1, Cristian Merino1

  • 1Centro de Química Médica, Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago 7780272, Chile.

Pharmaceuticals (Basel, Switzerland)
|January 25, 2025
PubMed
Summary
This summary is machine-generated.

This study developed a machine learning model to predict FLT3 inhibitor potency for Acute Myeloid Leukemia (AML) treatment. The model offers a user-friendly tool for faster drug discovery and development of targeted AML therapies.

Keywords:
AML treatmentFLT3 inhibitorsQSAR modelingcomputer-aided drug designligand-based drug design

More Related Videos

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
06:56

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

Published on: March 10, 2018

13.6K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.3K

Related Experiment Videos

Last Updated: May 30, 2025

Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors
09:11

Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors

Published on: November 23, 2019

6.6K
A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
06:56

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

Published on: March 10, 2018

13.6K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.3K

Area of Science:

  • Medicinal Chemistry
  • Computational Chemistry
  • Pharmacology

Background:

  • Acute Myeloid Leukemia (AML) poses therapeutic challenges, especially FLT3-mutated cases.
  • Existing FLT3 inhibitor models have limitations in dataset size, diversity, and accuracy.

Purpose of the Study:

  • Develop a robust, user-friendly Quantitative Structure-Activity Relationship (QSAR) model for FLT3 inhibitors.
  • Predict inhibitory potency (pIC50) to aid drug discovery.

Main Methods:

  • Trained a random forest regressor on a large dataset (1350 compounds, 1269 descriptors).
  • Validated the model using leave-one-out, 10-fold cross-validation (Q2=0.926), and external validation (R²=0.941).

Main Results:

  • Identified key molecular descriptors influencing FLT3 inhibitor potency.
  • Developed a computational tool for rapid pIC50 prediction and virtual screening.
  • Identified promising novel FLT3 inhibitors.

Conclusions:

  • The developed QSAR model significantly advances FLT3 inhibitor discovery.
  • Provides a reliable and efficient approach for early-stage AML drug development.
  • Accelerates the creation of targeted therapies for AML.